Reliable pre-eclampsia pathways based on multiple independent microarray data sets.

Area of Science:

• Genomics
• Molecular Biology
• Obstetrics

Background:

• Pre-eclampsia is a complex pregnancy disorder with varied clinical signs.
• Previous gene expression studies in pre-eclampsia yielded inconsistent results due to experimental artifacts.
• Identifying robust molecular pathways is crucial for understanding pre-eclampsia pathogenesis.

Purpose of the Study:

• To identify reliable pre-eclampsia-specific molecular pathways using multiple independent microarray datasets.
• To validate identified pathways using independent datasets and quantitative real-time PCR.
• To explore novel pathways associated with pre-eclampsia.

Main Methods:

• Utilized gene expression data from Gene Expression Omnibus (GEO) for control and preeclamptic placentas.
• Performed single-sample gene-set enrichment analysis on 9707 pathways from the Molecular Signatures Database.
• Employed t-test screening and recursive feature elimination for pathway selection, followed by validation on five datasets.
• Conducted quantitative real-time PCR on key genes (GABRA3, GCLC, GCLM, CDKN1C) in placental samples from 20 women.

Main Results:

• Identified a panel of ten pathways that accurately discriminate between pre-eclampsia and control groups.
• Discovered novel associations with pre-eclampsia, including the GABA receptor pathway.
• Confirmed previously linked pathways such as glutathione metabolism and CDKN1C.
• Observed significantly reduced mRNA expression of GABRA3, GCLC, GCLM, and CDKN1C in preeclamptic placentas.

Conclusions:

• Ten accurate and reliable pre-eclampsia-specific pathways were identified through multi-dataset analysis.
• Pathway-based classification offers a promising approach for elucidating pre-eclampsia pathogenesis.
• Altered expression in GABA receptor and glutathione pathways suggests new diagnostic or therapeutic targets.